Trial intelligence / Profile preview

Paroxetine in Chronic Primary Insomnia

NCT00178048Phase 4Completed

Sponsor
University of Pittsburgh
Start
Sep 1998
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Insomnia comparing Paroxetine + Sleep Hygiene with Placebo + Sleep Hygiene (2 arms). Primary endpoint: Diagnostic Response at 6 weeks. Started Sep 1998; status: completed.

02

Drugs

paroxetine
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00178048.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00178048.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call